Tabrecta 150 mg

Tabrecta 150 mg is a medicine authorised by Swissmedic under authorisation number 67648. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 April 2021 and the authorisation is limited until 06 March 2028. ATC code L01EX17 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 67648
  • ATC L01EX17
  • Synthetic medicines
Authorisation data
Authorisation number67648
NameTabrecta 150 mg
Full nameTabrecta 150 mg, Filmtabletten
Authorisation holderNovartis Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EX17
First authorisation26 April 2021
Authorisation validity06 March 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Tabrecta 150 mg, FilmtablettenA26 April 2021
2Tabrecta 200 mg, FilmtablettenA26 April 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1120Tablette(n)L01EX1707.16.1.A
2120Tablette(n)L01EX1707.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Tabrecta 150 mg authorised in Switzerland?

Yes. Tabrecta 150 mg is authorised by Swissmedic under authorisation number 67648, data as of 01 September 2026. The authorisation is limited until 06 March 2028.

Which dispensing category does Tabrecta 150 mg have?

Tabrecta 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Tabrecta 150 mg?

The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com